Šalis: Didžioji Britanija
kalba: anglų
Šaltinis: myHealthbox
Ethambutol Hydrochloride
Peckforton Pharmaceuticals Ltd
J04AK02.
Ethambutol Hydrochloride
400 mg
Film-coated Tablet
Oral use
Bottles containing 56 tablets or 60 tablets
POM - Prescription Only Medicine
Peckforton Pharmaceuticals Ltd
Antimycobacterial
It is indicated for the primary treatment and re-treatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large-tuberculinpositive reaction
Authorised
2010-09-07
PATIENT INFORMATION LEAFLET ETHAMBUTOL 400 MG TABLETS (Ethambutol Hydrochloride) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects get serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Ethambutol Tablets are and what they are used for 2. Before you take Ethambutol Tablets 3. How to take Ethambutol Tablets 4. Possible side effects 5. How to store Ethambutol Tablets 6. Further information 1. WHAT ETHAMBUTOL TABLETS ARE AND WHAT THEY ARE USED FOR The name of your medicine is Ethambutol Tablets. Ethambutol belongs to a group of medicines called antituberculosis drugs and is used for the treatment and prevention of tuberculosis, an infectious disease mainly affecting the lungs. 2. BEFORE YOU TAKE ETHAMBUTOL TABLETS DO NOT TAKE ETHAMBUTOL TABLETS: · if you have sight problems caused by inflammation of nerves in your eye (optic neuritis). · if you are allergic (hypersensitive) to ethambutol hydrochloride or to any of the other ingredients (see list under ‘What Ethambutol Tablets contain’ in Section 6). PROBLEMS WITH YOUR SIGHT You should have your eyesight checked before taking these tablets. If you notice any changes to your vision whilst taking these tablets, YOU SHOULD STOP TAKING THEM AND NOTIFY YOUR DOCTOR IMMEDIATELY. Very young children or patients with communication difficulties should be closely monitored for any signs of sight problems by their parents or carers. TAKING OTHER MEDICINES You should not take ethambutol tablets at the same time as antacid medicine Perskaitykite visą dokumentą
Ethambutol 400 mg Tablets Summary of Product Characteristics Updated 11Jun2015 | Peckforton Pharmaceuticals 1. Name of the medicinal product Ethambutol 400 mg Tablets 2. Qualitative and quantitative composition Each film coated tablet contains 400mg Ethambutol Hydrochloride. For a full list of excipients see section 6.1. 3. Pharmaceutical form Film coated tablet. Smooth, grey, circular, biconvex film coated tablet, plain on both sides. 4. Clinical particulars 4.1 Therapeutic indications The primary treatment and retreatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large tuberculinpositive reaction. Ethambutol should only be used in conjunction with other antituberculous drugs to which the patient's organisms are susceptible. Consideration should be given to official guidance on the appropriate use of antibacterial agents 4.2 Posology and method of administration _Route of administration_: Oral _Posology:_ Recommended Dosage The dosage of ethambutol must be adjusted according to the body weight of the patient. This drug should not be used as a sole antituberculosis agent, but should be given with at least one other antituberculosis drug to avoid development of resistant strains. The usual daily dosage is 1525mg/kg body weight given as a single dose. _Adults_ For primary treatment and prophylaxis: Ethambutol should be administered in a single daily dose of 15mg/kg, concomitant drugs being maintained at their recommended dosage levels. For retreatment: For the first 60 days of treatment, ethambutol should be administered in a single daily dose of 25mg/kg. Thereafter the dosage should be reduced to 15mg/kg, concomitant drugs being maintained at their recommended dosage levels. _Children_ For primary treatment and retreatment: For the first 60 Perskaitykite visą dokumentą